Ha habido 50 transacciones internas recientes registradas para Vyant Bio, Inc. (VYNT), incluyendo 48 compras y 1 venta. El total de compras internas fue valorado en $982.63K y el total de ventas internas en $888.44.
Internos destacados con actividad reciente incluyen Fletcher R John, Horobin Joanna, Harris Geoffrey E.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — VYNT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2023-01-17 |
Fletcher R John |
Director |
Concesión de RSU |
4,368 |
- |
- |
23,895 |
| 2023-01-17 |
Horobin Joanna |
Director |
Concesión de RSU |
7,526 |
- |
- |
23,123 |
| 2023-01-17 |
Harris Geoffrey E. |
Director |
Concesión de RSU |
5,712 |
- |
- |
19,761 |
| 2023-01-17 |
Hansen Paul R. |
Director |
Concesión de RSU |
4,032 |
- |
- |
152,995 |
| 2022-11-18 |
Harris Geoffrey E. |
Director |
Venta Informativa |
666 |
$1.33 |
$888.44 |
14,019 |
| 2022-10-17 |
Fletcher R John |
Director |
Concesión de RSU |
8,290 |
- |
- |
97,649 |
| 2022-10-17 |
Horobin Joanna |
Director |
Concesión de RSU |
14,285 |
- |
- |
77,994 |
| 2022-10-17 |
Harris Geoffrey E. |
Director |
Concesión de RSU |
10,841 |
- |
- |
73,920 |
| 2022-10-17 |
Hansen Paul R. |
Director |
Concesión de RSU |
7,653 |
- |
- |
744,826 |
| 2022-07-18 |
Fletcher R John |
Director |
Concesión de RSU |
4,696 |
$0.00 |
$0.47 |
89,359 |
| 2022-07-18 |
Horobin Joanna |
Director |
Concesión de RSU |
8,092 |
$0.00 |
$0.81 |
63,709 |
| 2022-07-18 |
Harris Geoffrey E. |
Director |
Concesión de RSU |
6,141 |
$0.00 |
$0.61 |
63,079 |
| 2022-07-18 |
Hansen Paul R. |
Director |
Concesión de RSU |
4,335 |
- |
- |
737,173 |
| 2022-04-18 |
Fletcher R John |
Director |
Concesión de RSU |
3,944 |
$0.00 |
$0.39 |
84,663 |
| 2022-04-18 |
Horobin Joanna |
Director |
Concesión de RSU |
6,796 |
$0.00 |
$0.68 |
55,617 |
| 2022-04-18 |
Harris Geoffrey E. |
Director |
Concesión de RSU |
5,157 |
$0.00 |
$0.52 |
56,938 |
| 2022-04-18 |
Hansen Paul R. |
Director |
Concesión de RSU |
3,640 |
- |
- |
732,838 |
| 2022-04-18 |
Boehm Marcus |
Director |
Concesión de RSU |
7,281 |
- |
- |
56,484 |
| 2022-03-30 |
Fletcher R John |
Director |
Concesión de RSU |
43,478 |
$0.00 |
$4.35 |
55,875 |
| 2022-03-30 |
Horobin Joanna |
Director |
Concesión de RSU |
43,478 |
$0.00 |
$4.35 |
48,821 |
| 2022-03-30 |
Harris Geoffrey E. |
Director |
Concesión de RSU |
43,478 |
$0.00 |
$4.35 |
51,781 |
| 2022-03-30 |
Mcleod Howard |
Director |
Concesión de RSU |
43,478 |
- |
- |
43,927 |
| 2022-03-30 |
Yeh Yung-ping |
Director |
Concesión de RSU |
43,478 |
- |
- |
56,240 |
| 2022-03-30 |
Hansen Paul R. |
Director |
Concesión de RSU |
43,478 |
- |
- |
729,198 |
| 2022-03-30 |
Boehm Marcus |
Director |
Concesión de RSU |
43,478 |
- |
- |
49,203 |
| 2022-03-30 |
Fletcher R John |
Director |
Concesión de RSU |
24,844 |
$0.00 |
$2.48 |
80,719 |
| 2022-03-15 |
Roberts John A |
Chief Executive Officer |
Concesión de RSU |
150,000 |
$1.00 |
$150K |
150,000 |
| 2022-03-15 |
Lafrence Andrew D.c. |
Chief Financial Officer |
Concesión de RSU |
110,000 |
- |
- |
110,000 |
| 2022-03-15 |
Fremeau Robert Thomas Jr. |
Chief Scientific Officer |
Concesión de RSU |
75,000 |
- |
- |
75,000 |
| 2022-01-18 |
Fletcher R John |
Director |
Concesión de RSU |
3,721 |
$1.31 |
$4.87K |
12,397 |
| 2022-01-18 |
Horobin Joanna |
Director |
Concesión de RSU |
5,343 |
$1.31 |
$7K |
5,343 |
| 2022-01-18 |
Harris Geoffrey E. |
Director |
Concesión de RSU |
4,055 |
$1.31 |
$5.31K |
8,303 |
| 2022-01-18 |
Hansen Paul R. |
Director |
Concesión de RSU |
2,862 |
$1.31 |
$3.75K |
685,720 |
| 2022-01-18 |
Boehm Marcus |
Director |
Concesión de RSU |
5,725 |
$1.31 |
$7.5K |
5,725 |
| 2021-12-06 |
Boehm Marcus |
Director |
Compra Informativa |
5,000 |
$1.69 |
$8.45K |
128,786 |
| 2021-11-24 |
Roberts John A |
Chief Executive Officer |
Compra Informativa |
5,000 |
$2.02 |
$10.1K |
39,807 |
| 2021-11-23 |
Lafrence Andrew D.c. |
Chief Financial Officer |
Compra Informativa |
5,000 |
$2.00 |
$10K |
34,336 |
| 2021-11-23 |
Lafrence Andrew D.c. |
Chief Financial Officer |
Compra Informativa |
5,000 |
$2.00 |
$10K |
34,292 |
| 2021-11-22 |
Yeh Yung-ping |
Chief Innovation Officer |
Compra Informativa |
500 |
$2.05 |
$1.03K |
12,762 |
| 2021-11-09 |
Hansen Paul R. |
Director |
Herencia (Compra) |
6,783 |
- |
- |
159,778 |
| 2021-11-01 |
Fremeau Robert Thomas Jr. |
Chief Scientific Officer |
Concesión de RSU |
250,000 |
$2.55 |
$637.5K |
250,000 |
| 2021-10-28 |
Fremeau Robert Thomas Jr. |
Chief Scientific Officer |
Compra Informativa |
1,000 |
$2.19 |
$2.19K |
1,000 |
| 2021-10-27 |
Boehm Marcus |
Director |
Compra Informativa |
5,000 |
$2.10 |
$10.5K |
123,786 |
| 2021-10-25 |
Fremeau Robert Thomas Jr. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2021-09-29 |
Boehm Marcus |
Director |
Compra Informativa |
5,000 |
$2.44 |
$12.2K |
118,786 |
| 2021-08-25 |
Boehm Marcus |
Director |
Compra Informativa |
5,000 |
$2.58 |
$12.88K |
113,786 |
| 2021-08-25 |
Yeh Yung-ping |
Chief Innovation Officer |
Compra Informativa |
1,000 |
$2.64 |
$2.64K |
12,262 |
| 2021-08-23 |
Roberts John A |
Chief Executive Officer |
Compra Informativa |
10,406 |
$2.41 |
$25.08K |
34,807 |
| 2021-08-19 |
Hansen Paul R. |
Director |
Compra Informativa |
20,000 |
$2.35 |
$47K |
617,957 |
| 2021-07-28 |
Boehm Marcus |
Director |
Compra Informativa |
5,000 |
$2.92 |
$14.62K |
108,786 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento